Heparin cofactor 2
| GO Term | Evidence Code | Reference |
|---|---|---|
| chemotaxis |
|
|
| blood coagulation |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| endoplasmic reticulum lumen |
| GO Term | Evidence Code | Reference |
|---|---|---|
| endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| serine-type endopeptidase inhibitor activity | ||
| heparin binding |
|
|
| Pathway Name | Organism |
|---|---|
| Amplification and propagation of coagulation cascade | Homo sapiens |
| Fibrin formation | Homo sapiens |
| Post-translational protein phosphorylation | Homo sapiens |
| Regulation of IGF Activity by IGFBP | Homo sapiens |
| Regulation of clotting cascade | Homo sapiens |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0111901 | heparin cofactor II deficiency | |
| DOID:0050117 | disease by infectious agent |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026